We focused on the widely known PBC data from a clinical trial [32] including repeated measures of 11 biomarkers (7 continuous and 4 binary), such as bilirubin value, albumin value or presence of hepatomegaly, and 3 additional demographic variables collected at the enrollment in the study (see Table S2 in supplementary material for the complete list). The gene discussed is ALB; the disease is Hepatomegaly.